WASHINGTON — The Food and Drug Administration approved the Pfizer COVID-19 vaccine for children ages 5 to 11 on Friday for emergency use.

28 million American children could be eligible for the kid-size dose which is one third of the amount given to teens and adults, as early as next week.

Then Tuesday, CDC advisers will detailed recommendations as to which youngsters should get vaccinated, with a final decision by the agency’s director expected shortly afterwards.

Once the CDC issues its ruling, eligible kids will get two shots, three weeks apart.

Young children are at much lower risk of hospitalization or death from COVID-19 than adults. Only 100 child deaths have been reported from the virus since the start of the coronavirus pandemic, according to the FDA.